Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs (English, HTML)

View metadata and access the original English HTML file: Notice: Phase III of Pre-Market Transparency Initiatives for Prescription Drugs.

Format

HTML

Access

file-only

Publisher-reported update

2023-12-24

As a regulator, Health Canada plays an important role in protecting the health and safety of Canadians. Health Canada is committed to being transparent and open about its activities and to making timely and useful information available about health products and health product submissions. Greater transparency and openness with Canadians strengthens the trust in our regulatory decisions, and ultimately supports Canadians in making better decisions about their health.

Access original file